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PENGHASILAN KACA AKTIF BIO BERASASKAN PELEBURAN DAN 
PENILAIAN KEBOLEHSERASIAN BIO TERHADAP SEL INDUK PULPA 
GIGI 
 
ABSTRAK 
Kaca aktif bio berupaya untuk melekap dan membentuk tisu keras dan tisu 
lembut, seterusnya menggalakkan pertumbuhan tulang. Kaca aktif bio 45S5 dengan 
komposisi 46.1% SiO2, 26.9% CaO, 24.4% Na2O dan 2.5% P2O5 dalam peratusan 
mol (mol.%) dan satu komposisi baru (BG 44S) dengan jaringan kesambungan yang 
sama telah dihasilkan menggunakan kaedah peleburan pada suhu dan tempoh 
rendaman yang sama. Komposisi 44S dicadangkan untuk menurunkan suhu 
peleburan ketika penghasilan. Penyediaan kaca aktif bio merangkumi proses 
pengelompokan, pencampuran, peleburan pada 1400 °C, lindap-kejut air, pengisaran 
dan pengayakan. Kaca aktif bio 45S5 mempunyai purata saiz zarah lebih rendah 
(11.8 μm) berdasarkan analisis saiz zarah. Kedua-dua kaca aktif bio berada di dalam 
fasa amorf berdasarkan analisis pembelauan sinar-X (XRD) dan mempunyai 
kebanyakannya jaringan silikat berdasarkan kehadiran kumpulan berfungsi Si-O-Si 
menurut Spektroskopi Inframerah Transformasi Fourier. Kedua-dua jenis kaca aktif 
bio ini menjalani pengeraman di dalam cecair badan tiruan (SBF) untuk menilai 
tahap bioaktiviti untuk pembentukan lapisan hidroksi karbonat apatit (HCA) yang 
diikuti dengan pencirian. Kumpulan berfungsi bagi ikatan P-O dan C-O wujud pada 
hari pertama bagi kaca aktif bio 44S, manakala wujud pada hari ketujuh bagi kaca 
aktif bio 45S5, yang dikaitkan dengan pembentukan lapisan HCA. Pembentukan 
lapisan hidroksiapatit (HA) di atas kedua-dua permukaan kaca aktif bio bermula pada 
xx 
 
hari pertama, diikuti dengan pembentukan kelompok kristal HCA pada hari 21 
berdasarkan imej mikroskop pengimbas elektron dan analisis spektroskopi serakan 
tenaga sinar-X (EDX) selepas direndam di dalam cecair SBF. Pembebasan ion 
daripada kedua-dua kaca aktif bio, terutamanya ion kalsium dan fosforus di dalam 
cecair SBF dan Medium Eagle Terubahsuai oleh Dulbecco (DMEM) berdasarkan 
spektrometer pemancaran optik - plasma terganding beraruhan (ICP-OES) 
menunjukkan bahawa pembentukan HCA berlaku pada kedua-dua kaca aktif bio 
yang berkait rapat dengan peningkatan nilai pH selepas melalui pengeraman selama 
240 minit. Sel induk pulpa gigi (DPSC) menunjukkan kelangsungan sel yang lebih 
tinggi di dalam cerakin Alamar Blue (AB) dan perkembangbiakan sel yang lebih 
tinggi dalam cerakin metiltiazolildifenil-tetrazolium bromida (MTT) apabila terdedah 
kepada nisbah serbuk kaca aktif bio kepada cecair yang lebih rendah (1 – 2 mg/ml) 
untuk kedua-dua media yang mengandungi BG yang menunjukkan biokeserasian 
terhadap DPSC. Pendedahan DPSC kepada media yang mengandungi nisbah serbuk 
BG kepada cecair yang lebih rendah (1 – 2 mg/ml) bagi kedua-dua kaca aktif bio 
45S5 dan 44S tanpa agen induktif osteogenik menunjukkan sifat induksi osteogenik 
berdasarkan ujian MTT, aktiviti fosfatase beralkali (ALP) dan cerakin jumlah DNA. 
DPSC yang terdedah kepada medium yang mengandungi agen induktif osteogenik 
menunjukkan pemineralan berlebihan berdasarkan pewarnaan von Kossa dan 
Alizarin merah. Media yang mengandungi kaca aktif bio 45S5 dan 44S meransang 
sifat osteogenik dalam DPSC. Kesimpulannya, kaca aktif bio 45S5 dan 44S berjaya 
dihasilkan dan keduanya adalah bioserasi terhadap DPSC hingga meningkatkan 
kelangsungan, perkembangbiakan dan pembezaan osteogenik. Oleh itu, kaca aktif 
bio ini menunjukkan potensi untuk aplikasi dalam pergigian regeneratif. 
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MELT DERIVED FABRICATION OF BIOACTIVE GLASS AND 
BIOCOMPATIBILITY EVALUATION TOWARDS DENTAL PULP STEM 
CELL 
 
ABSTRACT 
Bioactive glass (BG) has the ability to bond to hard and soft tissues, and 
promotes bone growth. BG 45S5, with composition of 46.1% SiO2, 26.9% CaO, 
24.4% Na2O, and 2.5% P2O5 in mole percentages (mol.%), and a new composition 
(BG 44S), with similar network connectivity were fabricated via melt derived route 
using similar melting temperature and soaking time. The 44S composition was 
proposed to decrease melting temperature during fabrication. The BG preparations 
included batching, mixing, melting at 1400 °C, water quenching, milling, and 
sieving. BG 45S5 possessed lower average particle size (11.8 μm) based on the 
particle size analysis. Both BG were in amorphous phase based on X-Ray Diffraction 
(XRD) analyses and contained mainly silicate network, with Si-O-Si functional 
groups, using Fourier Transform Infrared spectroscopy. Both BG were subjected to 
simulated body fluid incubation to assess the bioactivity for hydroxyl carbonate 
apatite (HCA) layer formation, followed by characterisations. Functional groups of 
P-O and C-O bonds, which attributed to HCA layer formation were present at day 1 
for BG 44S, and at day 7 for BG 45S5. The hydroxyapatite (HA) layer started to 
develop on both BG surfaces at day 1, followed by formation of HCA cluster crystal 
at day 21 based on Scanning Electron Microscope (SEM) images and Energy 
Dispersive X-ray Spectroscopy (EDX) analyses upon immersion in SBF solution. 
Ionic release from both BG, especially calcium and phosphorus ions in SBF solution 
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and Dulbecco’s Modified Eagle Medium (DMEM) based on the inductively coupled 
plasma – optical emission spectrometer showed that HCA formation occurred on 
both BG surfaces, which corresponded to the increasing pH within 240 minutes 
incubation. Exposure of dental pulp stem cells (DPSC) to lower BG powder to liquid 
ratio (1 – 2 mg/ml) for both BG-conditioned media showed higher cell viability in 
Alamar Blue assay and higher cell proliferation in methylthiazolyldiphenyl-
tetrazolium bromide (MTT) assay, highlighting biocompatibility towards DPSC. 
DPSC exposed to lower BG powder to liquid ratio (1 – 2 mg/ml) for both BG 45S5 
and 44S without an osteogenic inductive agent showed osteoinduction properties 
based on MTT, alkaline phosphatase activity, and total DNA assays. DPSC exposed 
to medium containing osteogenic inductive agent showed greater mineralisation 
based on von Kossa and Alizarin red staining. The 45S5 and 44S BG-conditioned 
media promoted osteogenic properties of DPSC. In conclusion, BG 45S5 and 44S 
were successfully fabricated and biocompatible towards DPSC, thus enhancing its 
viability, proliferation, and osteogenic differentiation. Hence, these bioactive glasses 
showed potential for application in regenerative dentistry. 
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CHAPTER 1 
INTRODUCTION 
1.1 Bioglass as biomaterial 
Bioactive materials (biomaterial) are materials which can stimulate a biological 
response at the interface of the materials by forming bonds between the tissues and 
the material itself. Furthermore, biomaterial are classified into Class A and Class B. 
Osteoproductive material (Class A) is able to produce both an intracellular and 
extracellular responses at its interface (Cao and Hench, 1996). Bioactive glass (BG) 
is classified as Class A biomaterial that is able to form bonds with both hard and soft 
tissues such as bone and teeth. 45S5 Bioglass
®
 was the first fabrication of BG by 
Professor Hench in 1969 which having composition of 46.1% SiO2, 26.9% CaO, 
24.4% Na2O and 2.5% P2O5 in mole percentages (mol.%).  
BG can be fabricated in many forms that are suitable for various applications such as 
powders, rods, disc and also nanoparticles. Two methods commonly used to fabricate 
BG are through melt derived route (Ibrahim et al., 2017a) and also sol-gel route 
(Noor et al., 2016b). Melt derived route requires high temperature usually above 
1000 °C while sol-gel route usually requires temperature below 1000 °C. However, 
fabrication of BG requires longer period for sol-gel route compared to melt derived 
route.  
The bioactivity of BG is represented by the formation of hydroxyapatite (HA) and 
hydroxylcarbonate apatite (HCA) layer on BG surfaces when it is dissolved in 
simulated body fluids (SBF) (Kokubo and Takadama, 2006). Furthermore, the 
bioactivity of BG can also be predicted by calculating the network connectivity (Nc) 
based on its composition especially for melt derived bioactive glass. The 45S5 
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Bioglass
®
 has network connectivity of 2.12 (Nc = 2.12). However, the bioactive 
glasses which had network connectivity (Nc) more than 2.6 are likely to be less 
bioactive (Jones, 2013; O’Donnell et al., 2008a).  
The BG is widely used and being studied especially in dental applications for 
restorative and endodontic therapy. Recently, the BG has been studied for dental 
desensitising agent (Ma et al., 2017), dentine mineralisation (Wang et al., 2011b), 
antibacterial purposes (Liu et al., 2016a) and as inorganic fillers (Alhashimi et al., 
2017). Furthermore, the effect of BG towards many cells is studied for 
biocompatibility (De Caluwé et al., 2017), cell viability, differentiation ability 
(Houreh et al., 2017), cell proliferation and also osteoinductive purposes (Silva et al., 
2017).   
Dental pulp stem cells (DPSC) can be obtained from the dental pulp tissue located in 
the central part of the tooth within the dentin. Furthermore, Gronthos et al., (2002) 
showed that DPSC possessed high proliferative potential, self-renewal capacities and 
also multi-lineage differentiation. Tissue engineering requires materials which are 
biocompatible that can carry signalling molecules and cells that are easily available. 
Thus, bioactive materials such as BG are needed in tissue engineering due to the 
ionic dissolution products release from the BG itself which can stimulate cell 
proliferation and also osteoblast proliferation (Gentleman et al., 2010). 
1.2 Problem statement 
Common oral diseases causes damaged to teeth and the teeth need to be repaired and 
treated. It is considered a major health problem when tooth loss happens commonly 
caused by periodontal disease, trauma and caries (Zhang et al., 2006). Periodontal 
disease and caries are two major dental diseases which have high prevalence rates 
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worldwide (Vaithlingam et al., 2017). World Health Organisation (WHO) stated 
more than 95% adults have caries which often leading to discomfort and pain (World 
Health Organisation, 2017). For adults in Malaysia, from 1990 until 2000 shows that 
dental caries is increasing with increasing age (Oral Health Division, 2011). Caries 
may develop in the crowns and roots of teeth beginning in early childhood. Caries 
can be treated by dental materials but can cause the tooth to be destroyed without 
proper care (Selwitz et al., 2007). Caries can be the primary cause for oral pain and 
also tooth loss. Thus, finding solutions to prevent and also treat dental caries has 
become critical (Li et al., 2013).   
Currently, various dental materials exist for treatment of caries such as mineral 
trioxide aggregate (MTA) (Flores-Ledesma et al., 2017), amalgam, glass ionomer 
cement (GIC) (Krämer et al., 2017) and dental composite (Chatzistavrou et al., 
2015). There are many developments and tests of dental materials as protective 
agents for the dentin-pulp complex in dental tissue engineering especially cases 
involving pulpal exposure or near exposure. Furthermore, biomaterials such as BG 
are suitable for bone and teeth repair due to the released ionic dissolution products 
that could promote the cells toward a path of regeneration and also self-repair. Thus, 
BG is very much needed for dental materials especially for dental pulp tissue 
regeneration and repair.    
Fabrication of BG 45S5 via melt derived route required high melting temperature. In 
the current project, two bioactive glasses were fabricated via melt derived route using 
the same melting temperature with the same soaking time. The fabricated bioactive 
glasses have the same value of network connectivity (Nc) with the BG 45S5 (Nc = 
2.12) but with different composition. O’Donnell et al., (2008) discovered 
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composition of the bioactive glass by substituting P2O5 and also fixing the 
Na2O:CaO ratio (1.00:0.87). The current project fabricates a new composition of 
bioactive glass by fixing the Na2O:CaO ratio (1.00:0.87) and contain similar amount 
of P2O5 with the 45S5 bioactive glass based on Appendix A. Thus, composition of 
the new BG being modified in order to decrease the melting temperature that is 
required for fabrication process. Furthermore, new composition of BG has been 
fabricated at lower melting temperature which helps to reduce the cost during 
manufacturing process (Ibrahim et al., 2017a).  
BG 45S5 being market as NovaBone (NovaBone Products LLC) used for bone 
regeneration and Novamin
®
 (NovaMin Technology, FL) which used for 
hypersensitivity in Sensodyne Repair and Protect toothpaste (Jones, 2013). 
Currently, BG 45S5 being added into other dental materials and test towards DPSC. 
However, limited study is available for BG 45S5 towards DPSC especially for cell 
culture studies. Thus, characteristic of both bioactive glasses using in vitro 
bioactivity tests and effect of the fabricated bioactive glasses towards DPSC were 
studied in the current project. Therefore, the fabricated bioactive glasses are 
investigated as usage for future dental materials. 
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1.3 Objectives of the project 
The general objective of the project is to develop bioactive glasses by using melt 
derived method and assess its compatibility towards cells. The specific objectives of 
the project are as listed below: 
i. To fabricate bioactive glasses by using melt derived method.  
ii. To characterise the physical properties of bioactive glasses by using in vitro 
bioactivity tests. 
iii. To assess the biocompatibility of melt derived bioactive glasses towards 
human dental pulp stem cells (DPSC) using Alamar Blue (AB) and MTT 
assays. 
iv. To assess the osteoinduction properties of melt derived bioactive glasses 
towards human dental pulp stem cells (DPSC) using MTT assay, alkaline 
phosphatase (ALP) activity, total DNA assay, Von Kossa staining and 
Alizarin red staining.    
 
1.4 Research questions 
The research questions of the project are as listed below: 
i. Are both bioactive glasses able to be fabricated by using melt derived 
method? 
ii. Are the physical properties of both bioactive glasses different after in 
vitro bioactivity tests? 
iii. Are both bioactive glasses biocompatible to DPSC? 
iv. Does DPSC show osteoinduction properties upon exposure towards both 
bioactive glasses? 
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1.5 Research hypothesis 
The hypotheses of the project are as listed below: 
i. Both bioactive glasses are able to be fabricated by melt derived method. 
ii. Physical properties of both bioactive glasses change after in vitro bioactivity 
tests. 
iii. Both bioactive glasses are biocompatible to DPSC. 
iv. DPSC able to show osteoinduction properties upon exposure towards both 
bioactive glasses. 
 
1.6 Research approaches 
The bioactive glasses that contain SiO2, CaCO₃, Na2CO3 and P₂O₅ as raw materials 
were fabricated using melt derived method, subjected to characterisation and 
bioactivity investigations. The BG powders were characterised using 
thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC), 
particle size analysis, x-ray diffraction (XRD) analysis, x-ray fluorescence (XRF)  
and fourier transform infrared (FTIR) spectroscopy. Then, the bioactive glasses were 
subjected to simulated body fluid (SBF) incubation to assess bioactivity for 
formation of hydroxyapatite (HA) layer followed by characterisation using fourier 
transform infrared (FTIR) spectroscopy, pH evaluation, field emission scanning 
electron microscope (FESEM), energy dispersive x-ray spectroscopy (EDX) and 
inductively coupled plasma – optical emmision spetrometer (ICP–OES).  
The biocompatibility of bioactive glasses was assessed using BG-conditioned 
medium with different powder to liquid ratio (1, 1.5, 2, 4 and 6 mg/ml) towards 
dental pulp stem cells (DPSC) using Alamar Blue and MTT assays. The osteogenic 
medium were prepared using BG-conditioned medium with different powder to 
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liquid ratio (1, 2 and 4 mg/ml) by adding osteogenic inductive agents. Then, the 
osteogenic medium were exposed toward dental pulp stem cells (DPSC) to assess 
osteoinduction properties using MTT assay, alkaline phosphatase (ALP) activity, 
total DNA assay, Von Kossa and Alizarin red stainings. The flow chart of the 
experimental procedure is shown in Figure 1.1 respectively.  
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Bioactive glass preparation 
 Different composition of 
BG melting at 1400 
°
C with 
1.5 hours 
 BG 45S5 composition 
based on mole percentage 
with SiO₂ (46.13), CaO 
(26.91), Na₂O (24.35) and 
P₂O₅ (2.60) 
 BG 44S composition based 
on mole percentage with 
SiO₂ (46.24), CaO (23.80), 
Na₂O (27.36) and P₂O₅ 
(2.60) 
 
 
 
  
Objective 1 
Fabrication of bioactive 
glasses by melt derived 
method 
 TGA/DSC 
 XRD 
 XRF 
 PSA 
 FTIR 
 SEM 
 EDX 
Ion dissolution from BG in 
SBF and DMEM 
 Different composition of 
BG (45S5 and 44S) 
 Ratio 2 mg/ml  
 
In vitro bioactivity tests 
 
 Different composition of 
BG (45S5 and 44S)  FTIR 
 pH evaluation 
 SEM 
 EDX 
 ICP-OES 
 Alamar Blue 
assay 
 MTT assay 
 MTT Assay 
 Alkaline 
phosphatase 
(ALP) activity 
 Total DNA 
assay 
 Von kossa 
staining 
 Alizarin red 
staining 
Osteogenic medium 
preparation 
 Different composition of 
BG (45S5 and 44S) 
 Different concentration of 
powder to liquid ratio (1, 2 
and 4 mg/ml 
BG-conditioned medium 
preparation 
 Different composition of 
BG (45S5 and 44S) 
 Different concentration of 
powder to liquid ratio (1, 
1.5, 2, 4 and 6 mg/ml) 
Objective 2 
Characterise the physical 
properties of the bioactive 
glasses 
Objective 3 
Assess biocompatibility 
of melt derived bioactive 
glasses towards DPSC 
Figure 1.1: The flow chart of the experimental procedure. 
Objective 4 
Assess osteoinduction 
properties of melt derived 
bioactive glasses towards 
DPSC 
Procedure Objectives Testing 
9 
 
CHAPTER 2  
LITERATURE REVIEW 
2.1 Bioactive materials 
The basic function of a biomaterial is to replace damaged or disease tissues (Maçon 
et al., 2017). Bioactivity reflects the characteristics for a material that is able to create 
bonding with the host tissues. Bioactive materials is defined as materials that are able 
to induce specific biological activity at the interface of the material due to the 
bonding created between the living tissues and the material itself (Polymeris et al., 
2017). Currently, biomaterials received extensive researched for commercialisation 
and used especially for biomedical application. Furthermore, biomaterials were 
widely used especially in dental applications and medical field.  
Bioactive materials include hydroxyapatite (HA) ceramics, bioactive glass, bioactive 
glass ceramics and also bioactive glass composite. Moreover, bioactive materials 
were classified into 2 classes which are Class A and Class B (Cao and Hench, 1996). 
Class A is for osteoproductive materials where the materials itself induce an 
intracellular and an extracellular response at the interface of the materials. 
Meanwhile, Class B is osteoconductive materials that induce an extracellular 
response only at the interface of the materials. Bioactive glasses were classified as 
biomaterials Class A due to the formation of bonding with soft and hard tissues (Cao 
and Hench, 1996).   
2.2 Bioactive glass 
Bioactive glass (BG) was discovered as one of the bioactive materials Class A 
possessing osteoconductive and osteoinductive properties. There were various BG 
compositions available in the literature. The first fabrication of bioactive glass which 
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is 45S5 Bioglass
®
 was made by Professor Hench in 1969. BG 45S5 contained 46.1% 
SiO2, 26.9% CaO, 24.4% Na2O and 2.5% P2O5 in mole percentages (mol.%). BG can 
be fabricated in various forms such as powders (Zain et al., 2017), disc (Sheng et al., 
2016), films (Francis et al., 2016) and also bioceramic scaffolds (Bakopoulou et al., 
2016)  by using various methods of fabrication such as foam replica, melt derived, 
sol-gel and isostatic pressing. 
Products derived from BG 45S5 include NovaMin
®
 (NovaMin
®
 Technology, USA) 
and PerioGlass (NovaBone Osteobiologics, USA) (Deliormanlı, 2017). Both 
products were commercialised and widely used especially for dental applications. 
BG differ from any other bioactive materials since they possess certain properties 
and characteristics. Furthermore, bond formation with bone occurred when hydroxyl 
apatite (HA) and hydroxyl carbonate apatite (HCA) layer were detected upon BG 
45S5 immersion in simulated body fluid (SBF) (Groh et al., 2014).  
The ability of a BG to form hydroxyl apatite (HA) layer is often taken as an 
indication of its bioactivity when the bioactive glass is immersed in the simulated 
body fluid (SBF). BG is able to regenerate human bone, able to degrade in solution, 
release ionic dissolution products from the bioactive glass and also form apatite layer 
in short period of time on the surface of the bioactive glass. Furthermore, the ionic 
dissolution products from BG can be controlled and tailored for regeneration of 
tissues (Houreh et al., 2017). 
2.2.1  Properties of bioactive glass 
Nowadays, researchers investigated and fabricated new BG to improve the properties 
of BG 45S5 such as thermal, mechanical, physical and chemical. BG 45S5 possessed 
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excellent properties (Table 2.1) (Jones and Clare, 2012) in terms of thermal, 
mechanical, physical and chemical properties.  
Table 2.1: Properties of bioactive glasses. Adapted from Jones and Clare (2012). 
Property Value 
Density 2.7 
Network connectivity 2.12 
Glass transition temperature 538 °C 
Onset of crystallization 677 °C 
Refractive index 1.59 
Tensile strength 42 MPa 
Young’s modulus (stiffness) 35 MPa 
Shear modulus 30.7 GPs 
Facture toughness 0.6 MPa m
1/2
 
Vickers hardness 5.75 Gpa 
 
However, BG 45S5 had poor performance for mechanical properties (Vyas et al., 
2015) which had lower values in flexural strength, microhardness and compressive 
strength (Table 2.2). Hence, other materials such as cobalt oxide and nickel oxide are 
incorporated within BG to improve its mechanical properties (Vyas et al., 2015; 
Vyas et al., 2016). 
Table 2.2: Flexural strength, microhardness, compressive strength and density 
of bioactive glasses. Adapted from Jones and Clare (2012); Vyas, et al. (2015); 
Vyas et al. (2016). 
Bioactive glass 45S5 
NiO-1, NiO-2, NiO-
3 and NiO-4 
CoO-1, CoO-2, 
CoO-3 and CoO-4 
Density 2.7 2.82 − 2.97 2.81 − 2.87 
Compressive strength 
(MPa) 
68.82 76.92 − 82.13 76.72 − 82.13 
Flexural strength 
(Mpa) 
43.48 55.15 − 66.58 56.25 − 65.78 
Microhardness (GPa) 5.35 5.48 − 5.99 5.78 − 5.89 
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The network connectivity (Nc) is define as the average number of the bridging 
oxygen atoms bounded to a network forming cation, where a BO (bridging oxygen) 
atom is defined as an oxygen atom which is chemically bound to two network 
polyhedral which is shown in equation 2.1 (Christie et al., 2016; Hill and Brauer, 
2011).  
Network connectivity = 2 + BO – NBO    (2.1) 
                  G 
Where, 
   BO  = number of bridging oxygens 
   NBO  = number of non-bridging oxygens 
   G  = total number of glass-forming units 
 
The non-bridging oxygen (NBO) was the oxygen atom that does not connect with the 
two networks polyhedral. Network connectivity (Nc) has been used successfully to 
predict the bioactivity of the bioactive glass. BG with Nc of 2.6 is bioactive but Nc 
more than 3.0 are likely to inactive (Christie et al., 2016). Thus, network connectivity 
(Nc) was used to determine the ability of the bioactive glass to form apatite (Hill and 
Brauer, 2011). Network connectivity (Nc) of the BG depends on the composition of 
the BG since the presence of the network modifier cations may break the T–O–T 
bonds (where T is a network former, phosphorus in these glasses) (Christie et al., 
2016).  
Network connectivity of the BG can be modified by increasing or reducing the 
network modifier cations such as calcium and sodium for the BG composition. 
Lowering the BG network connectivity allows the BG to degrade easily and thus, 
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increasing its bioactivity (Christie et al., 2016). Moreover, structural, chemical, 
mechanical, bioactivity and the biological response of the BG can be determined by 
calculating the network connectivity (Arepalli et al., 2016). Lowering the Nc value of 
the BG results in better performance of the BG for cell compatibility and significant 
cell growth. Thus, the biocompatibility of the bioactive glass towards cell can also be 
determined by the network connectivity values. When increasing the composition of 
network modifiers, network connectivity of the bioactive glass tends to decrease 
leading to increased bioactivity properties (Arepalli et al., 2016).  
Biocompatibility towards cell culture studies showed that concentration of BG 
powders by modulating the powder to liquid ratio plays an important role even tough 
bioactive glass had their own values of network connectivity. Arepalli et. al, (2016) 
showed that all BG compositions were compatible with cells by using lower BG 
powder to liquid ratio (5 mg/ml). However, at higher BG powder to liquid ratio (10, 
25, 50, 100, 250 and 500 mg/ml) of all BG compositions resulted in decreased cell 
viability after 24 hours. Hence, the ionic dissolution from the bioactive glass plays an 
important role in cell culture studies (Arepalli et al., 2016). Ionic dissolution products 
from the BG produced biological responses and usually resulted in their biological 
performance (Figure 2.1). Many researches have been conducted to understand the 
ionic dissolution products from the inorganic materials incorporated with different 
composition of BG and improving the biological performance (Hoppe et al., 2011).  
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Figure 2.1: The biological responses to ionic dissolution products of bioactive 
glasses. Adapted from Hoppe et al., (2011).  
 
 
Figure 2.2 shows different methods of investigating the biological response of BG 
using different BG size (small, large) and shape (pellets, rods, disc and scaffolds) 
fabricated from different methods (Hoppe et al., 2011). Direct method (Figure 2.2) 
involved preparing BG in scaffolds form (Chen and Thouas, 2011) by seeding the 
cells directly on the scaffolds itself. Indirect method (Figure 2.2) usually involved 
BG prepared in powder form (Silver et al., 2001) by treating the cells with extracts 
containing ionic dissolution products from BG powders. Thus, ionic dissolution 
products can affect biological performance of cells.  
 
  
Bulk material 
density 
porosity 
crystallinity 
chemistry 
 
Surface properties 
surface area 
roughness 
surface charge/ zeta 
potential 
chemistry 
topography 
hardness/stiffness 
15 
 
 
 
 
Figure 2.2: Methods for analysing the cellular response to degradable 
biomaterials. Adapted from Hoppe et al., (2011). 
 
2.2.2  Synthesis of bioactive glass  
Briefly, there are three processing methods commonly used to fabricate BG powders. 
BG can be synthesised by melt quench, sol-gel and also melt anneal routes. Each 
route requires different temperature, processing method and time needed that may 
affect the structure of the bioactive glass. 
  
Direct method 
Indirect method 
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2.2.2(a) Melt quench route  
Fabrication of BG via melt quench route requires high melting temperature. All of 
the raw materials involved were melted together in a crucible followed by rapid 
quench in distilled water. Various melting temperatures can be used for this route 
including 1370 °C until 1475 °C (Elgayar et al., 2005), 1380 °C (Zarifah et al., 
2015), 1390 °C (O’Donnell et al., 2008a), 1400 °C (Ibrahim et al., 2017a) and up to 
1500 °C (Sharma et al., 2016). It was previously shown that BG can be melted at 
temperature less than 1400 °C with melting temperature of BG 45S5 at 1377 °C 
based on DSC/TGA results (Ibrahim et al., 2017a). 
However, the composition of BG itself may affect the BG melting temperature. 
O’Donnell et al., (2008a) proved that BG glass transition temperature decreased with 
increasing phosphate. Thus, each BG composition plays significant role in BG 
fabrication especially sodium which can reduce the melting temperature of BG 
(Wallace et al., 1999) due to disruption of BG structure. Furthermore, all of the 
bioactive glasses fabricated via melt quench route were in amorphous state even 
though its compositions were varied in mole percentages (Ibrahim et al., 2017b). BG 
fabricated via melt quench route can be produced in high volume within a short time 
with ease in obtaining the BG powders.  
It had been reported that melt quench route is a suitable alternative to produce 
tougher materials, controlled dissolution rates and also bioactivity (Sepulveda et al., 
2001). However, particle size of BG via melt quench route is larger compared to sol-
gel which can affect the bioactivity of BG itself (Sepulveda et al., 2001). It is proven 
that BG 58S with composition of SiO₂ (60 mol.%), CaO (36 mol.%) and P₂O₅ (4 
mol.%) as shown in Table 2.3 which had higher surface area with low particle size 
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released more calcium and silicon ions compared to melt derived BG 45S5 (Gong et 
al., 2014). Thus, ionic release of BG affects the differentiation, proliferation rate and 
mineralisation of cells due to different BG particle size. Hence, roughness and 
surface area of BG can be altered depending on the grinding process during 
fabrication (Sepulveda et al., 2002). Different grinding periods and media are able to 
change the range of the particle size obtained.  
2.2.2(b) Sol-gel route  
BG can also be fabricated through sol-gel route that affect the structure of the glass 
(Chen et al., 2008). Raw materials used for sol-gel route include tetraethoxysilane 
(TEOS, Si(OC2H5)4), calcium nitrate tetra-hydrate (Ca(NO3)2·4H2O), sodium nitrate 
(NaNO3) and also triethylphosphate (TEP, OP(OC2H5)3). These materials were added 
into the aqueous solution of nitric acid (HNO3) and subjected to stirring at room 
temperature for an hour. In order to form bioactive glass in gel form, the final 
solutions are kept at ambient temperature for 10 days to allow hydrolysis and 
polycondensation reactions to takes place. Then, the gel are aged between 60 °C until 
120 °C for 7 days followed by thermal treatment for 20 hours at 700 °C (Dziadek et 
al., 2016).  
The phosphate phases and crystalline silicate were present in the structure of BG 
synthesised via sol-gel route (Chen et al., 2008). Sol-gel route tend to produce lesser 
amount of BG in several days even though the process utilise temperature less than 
1000 °C. BG fabricated via sol-gel route exhibits more polymerised silicon oxygen 
network compared to melt quench route as shown in FTIR results (Dziadek et al., 
2016). Polymerised silicon oxygen network occurs in sol-gel route due to 
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stabilisation temperature for the gels, phase separation that can occur at sintering 
temperature and also presence of crystalline phases.  
Thus, temperature treatment of the gels enhances the incorporation of network 
modifier which is calcium and sodium into the silicate network and leads to 
depolymerisation (Dziadek et al., 2016). Furthermore, BG via sol-gel route exhibit 
higher dissolution rates compared to melt quench BG, which tend to increase the rate 
of HA formation (Sepulveda et al., 2002). However, sol-gel route is very sensitive 
and require certain conditions such as pH, ratio and types of reactants, atmospheric 
conditions and temperature (Rezabeigi et al., 2014). Thus, steps in sol-gel route need 
to be properly controlled and monitor to obtain final product.  
2.2.2(c) Melt anneal route 
BG can also be synthesised via melt anneal route (Arepalli et al., 2016). Melt anneal 
route is adopted for obtaining BG with enhanced mechanical properties (Srivastava 
and Pyare, 2012). Batches of BG with fixed composition of CaO (24.50 wt.%), Na₂O 
(24.50 wt.%) and P₂O₅ (6.00 wt.%) while different compositions of SiO₂ (45.00, 
44.00, 43.00, 42.00 and 41.00 wt.%) and CuO (1.00, 2.00, 3.00 and 4.00 wt.%) is 
melted in a platinum crucible at high temperature (1300 to 1500 °C) followed by 
pouring the molten glass on aluminium sheet or quenched in water. Then, the glass 
melts or frits that have been crushed were re-melted again followed by annealed for 
an hour and cooled to room temperature. The BG is melted again to ensure the 
homogeneity of the BG (Srivastava and Pyare, 2012) before anneal process begin.  
Furthermore, heat treated samples is able to exhibit micro-structural changes in phase 
composition that changes the reactivity for the surface of BG upon immersion in SBF 
(Satyanarayana et al., 2017). It can be seen that chemical durability, micro hardness, 
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flexural strength and density of BG increased with increasing copper oxide content 
(Srivastava and Pyare, 2012). However, higher copper oxide compositions in BG 
resulted in lower crystallisation temperature and reduce glass nucleation. Thus, 
bioactivity of the BG tends to decrease due to decreased in crystallisation 
temperature of BG (Srivastava and Pyare, 2012).    
2.2.3 Hydroxyl carbonate apatite (HCA) mechanism 
Hydroxyl carbonate apatite (HCA) is formed on the BG surface upon immersion in 
simulated body fluid (SBF) after a certain period of time (Bellucci et al., 2011). 
Hydroxyl carbonate apatite (HCA) has a similar mineral constituent to the bone. 
Furthermore, commercialised BG 45S5 regenerates bone better than the 
commercialised hydroxyapatite (HA) (De Caluwé et al., 2016). The HCA mechanism 
involved 11 reactions sequence on the surface of the BG implant, as described by 
Hench (2006). 
The first five sequences (Stage 1 until Stage 5) lead to formation of hydroxyl 
carbonate apatite (HCA) layer on the glass surface (Hench, 1998). After that, the 
sequences of reactions (Stage 6 until Stage 11) involve the effect of the ionic 
dissolution products that is released from the bioactive glass. The mechanism of 
HCA layer formation is shown in the following stages below:    
Stage 1: Rapid cation exchange of Na
+
 and/or Ca
2+
 with H
+
 from solution, creating 
silanol bonds (Si–OH) on the glass surface. 
Si–O–Na+ + H+ + OH- → Si–OH+ + Na+ (aq) + OH- 
The pH of the solution raises and a silica-rich (cation-depleted) region forms near the 
glass surface. Phosphate is also lost from the glass if present in the composition.  
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Stage 2: Soluble silica is lost in the form of Si(OH)4 to the solution due to Si–O–Si 
breaking bonds, leaving more Si–OH (silanols) at the glass–solution interface. 
Si–O–Si + H2O → Si–OH
+
 + OH–Si 
Stage 3: Condensation and repolymerisation of the Si–OH groups leaving the silica-
rich layer on the glass surface. 
Stage 4: Migration of Ca
2+ 
and PO4
3-
 groups to the glass surface through the silica-
rich layer followed by formation of rich film in amorphous CaO–P2O5 rich film on 
top of the silica-rich layer.  
Stage 5: The CaO–P2O5 rich film crystallises by incorporating OH
-
 and CO3
2-
 anions 
from the solution followed by formation of hydroxyl carbonate apatite (HCA). 
Stage 6: Adsorption of biological moieties in HCA layer. 
Stage 7: Action of macrophages. 
Stage 8: Osteoblast stem cells attachment. 
Stage 9: Differentiation and proliferation of osteoblasts. 
Stage 10: Generation of matrix. 
Stage 11: Crystallisation of matrix and growth of bone. 
The released ionic dissolution products (Si, Ca, Na and P) from the BG triggers 
intracellular and extracellular responses (Xynos et al., 2000). Effect from the ionic 
dissolution products are dose-dependent and response for each ions from the BG 
depends on the type of cells (Groh et al., 2014; Houreh et al., 2017; Liu et al., 2016a; 
Silva et al., 2017). The ability for bone bonding of BG is shown in the Figure 2.3 
(Hench, 2006). 
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Figure 2.3: Compositional diagrams for bone-bonding in weight percentage. 
Adapted from Hench (2006). 
 
BG compositional diagram shows different amount of SiO2, CaO and Na2O with 
fixed amount of P2O5 in weight percentages (Figure 2.3). Moreover, BG 45S5 
(region E) has the highest level of bioactivity, properties of bone bonding and also 
soft tissue bonding which is situated in the middle of the compositional diagram. 
2.3 Modification in properties and composition of bioactive glass 
The 45S5 Bioglass
®
 has become one of the bioactive materials which can be used 
especially in dentistry. Thus, until now researchers investigate the original properties 
of BG 45S5 followed by modifying the original BG 45S5 composition (Dziadek et 
al., 2016) and also adding other elements such as strontium, fluoride and nickel oxide 
for better purposes (Arepalli et al., 2016; De Caluwé et al., 2016; Vyas et al., 2016) 
as shown in Table 2.3. 
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Table 2.3: Modification in bioactive glass composition based on standard 45S5 
Bioglass
®
. 
Name of the 
bioactive 
glass 
Composition References 
BG 1, BG 2 
and BG 3 
- Fixed amount of SiO₂ (60 mol.%). 
- Various amount of Na2O (36, 32 and 28 
mol.%) and and P₂O₅ (4, 8 and 12 mol.%). 
Houreh et al., 
2017 
A2 - SiO₂ (40.0 mol.%), CaO (54.0 mol.%) and 
P₂O₅ (6.0 mol.%) with network 
connectivity value (2.20). 
Dziadek et al., 
2016 
Series I 
(ICSW2, 
ICSW3, 
ICSW4 and 
ICSW5) 
- Various amount of SiO₂ (47.84, 44.47, 
40.96 and 37.28 mol.%), Na₂O (26.67, 
27.26, 27.87 and 28.52 mol.%), CaO 
(23.33, 23.85, 24.39 and 24.95 mol.%) and 
P₂O₅ (2.16, 4.42, 6.78 and 9.25 mol.%). 
- All compositions have different network 
connectivity values (2.18, 2.30, 2.44 and 
2.62). 
O’Donnell et al., 
2008a 
 
O’Donnell et al., 
2008b 
Series I 
(ICSW1, 
ICSW6, 
ICSW7, 
ICSW8, 
ICSW9 and 
ICSW10) 
- Various amount of SiO₂ (48.98, 47.07, 
43.66, 40.71 and 38.14 mol.%), Na₂O 
(26.10, 26.67, 27.19, 28.12, 28.91 and 29.62 
mol.%), CaO (23.33, 23.78, 24.60, 25.31 
and 25.91 mol.%) and P₂O₅ (1.02, 1.95, 
3.62, 5.07 and 6.33 mol.%). 
- All compositions have same network 
connectivity value (2.08). 
58S - SiO₂ (58.00 wt.%), CaO (33.00 mol.%) and 
P₂O₅ (9.00 mol.%). 
Chen et al., 2008 
77S - SiO₂ (77.00 wt.%), CaO (14.00 mol.%) and 
P₂O₅ (9.00 mol.%). 
Series B 
(ICIE6, 
ICIE7, 
ICIE8, and 
ICIE9) 
- Fixed amount of Na2O (13.19 mol.%) and 
P₂O₅ (1.07 mol.%). 
- Various amount of SiO₂ (48.46, 53.46, 
56.46 and 61.00 mol.%) and CaO (37.27, 
33.27, 30.27 and 25.27 mol.%). 
- All compositions have different network 
connectivity values (1.96, 2.29, 2.47 and 
2.74). 
Elgayar et al., 
2005 
Series C 
(ICIE10, 
ICIE11, 
ICIE12, 
ICIE13 and 
ICIE14) 
- Fixed amount of K2O (13.19 mol.%) and 
P₂O₅ (1.07 mol.%). 
- Various amount of SiO₂ (48.46, 49.46, 
53.46, 56.46 and 61.00 mol.%) and CaO 
(37.27, 36.27, 33.27, 30.27 and 25.17 
mol.%). 
- All compositions have different network 
connectivity values (1.96, 2.04, 2.29, 2.47 
and 2.74). 
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Table 2.3: Modification in bioactive glass composition based on standard 45S5 
Bioglass
® 
(continued). 
Name of the 
bioactive 
glass 
Composition References 
Series D 
(ICIE15, 
ICIE16, 
ICIE17, 
ICIE18 and 
ICIE19) 
- Fixed amount of Na2O (6.60 mol.%), K2O 
(6.60 mol.%) and P₂O₅ (1.07 mol.%). 
- Various amount of SiO₂ (48.46, 49.46, 
53.46, 56.46 and 61.00 mol.%) and CaO 
(37.27, 36.27, 33.27, 30.27 and 25.17 
mol.%). 
- All compositions have different network 
connectivity values (1.96, 2.04, 2.29, 2.47 
and 2.74). 
Elgayar et al., 
2005 
Li25, Li50, 
Li75 and 
Li100  
- Fixed amount of SiO₂ (46.1 mol.%), CaO 
(26.9 mol.%) and P₂O₅ (2.6 mol.%). 
- Various amount of Na₂O (18.3, 12.2, 6.1 
and 0 mol.%). 
- Addition of Li₂O (6.1, 12.2, 18.3 and 24.4 
mol.%) 
Silva et al., 2017 
Zn0, Zn1, 
Zn2 and 
Zn3. 
- Various amount of SiO₂ (38.5, 37.0, 35.7 
and 34.3 mol.%), Na₂O (26.2, 26.5, 26.7 
and 27.0 mol.%), CaO (29.0, 29.2, 29.4 and 
29.6 mol.%) and P₂O₅ (6.3, 6.2 and 6.1 
mol.%). 
- Addition of ZnO (0, 1.0, 2.0 and 3.0 mol.%) 
- Network connectivity value (2.10). 
Huang et al., 2017 
NiO-1, NiO-
2, NiO-3 
and NiO-4 
- Various amount of SiO₂ (45.64, 45.20, 
44.71 and 44.25 mol.%), Na₂O (24.41, 
24.44, 24.46 and 24.49 mol.%), CaO 
(26.94, 26.96, 26.98 and 27.01 mol.%) and 
P₂O₅ (2.60 and 2.61 mol.%). 
- Addition of NiO (0.41, 0.82, 1.23 and 1.65 
mol.%). 
Vyas et al., 2016 
Sr-0, Sr-1, 
Sr-2, Sr-3 
and Sr-4 
- Fixed amount of Na2O (24.40 mol.%) and 
and P₂O₅ (2.60 mol.%). 
- Various amount of SiO₂ (46.10, 45.10, 
44.10 and 43.10 mol.%), and CaO (26.90 
and 24.22 mol.%). 
- Addition of SrO (1.00, 2.00 and 3.00 
mol.%). 
- All compositions have different network 
connectivity values (1.84, 1.94, 2.03 and 
2.11). 
Arepalli et al., 
2016 
45S5F - SiO₂ (47.71 mol.%), Na2O (25.19 mol.%), 
CaO (14.20 mol.%) and P₂O₅ (2.69 mol.%). 
- Addition of CaF2 (10.20 mol.%). 
- Network connectivity value (2.68). 
De Caluwé et al., 
2016 
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Table 2.3: Modification in bioactive glass composition based on standard 45S5 
Bioglass
® 
(continued). 
Name of the 
bioactive 
glass 
Composition References 
CF9 - SiO₂ (34.60 mol.%), CaO (50.38 mol.%) 
and P₂O₅ (5.74 mol.%). 
- Addition of CaF2 (9.28 mol.%). 
- Network connectivity value (2.08). 
De Caluwé et al., 
2016 
CoO-1, 
CoO-2, 
CoO-3 and 
CoO-4 
- Fixed amount of Na₂O (24.50 wt.%), CaO 
(24.50 wt.%) and P₂O₅ (6.0 wt.%). 
- Various amount of SiO₂ (44.50, 44.00, 
43.50 and 43.00 wt.%). 
- Addition of CoO (0.50, 1.00, 1.50 and 2.00 
wt.%). 
Vyas et al., 2015 
C1, C2, C3 
and C4 
- Fixed amount of Na₂O (24.50 wt.%), CaO 
(24.50 wt.%) and P₂O₅ (6.0 wt.%). 
- Various amount of SiO₂ (44.00, 43.00, 
42.00 and 41.00 wt.%). 
- Addition of CuO (1.00, 2.00, 3.00 and 4.00 
wt.%). 
Srivastava and 
Pyare, 2012 
BG_Na - SiO₂ (48.7 mol.%), Na₂O (33 mol.%), CaO 
(15.6 mol.%) and P₂O₅ (2.6 mol.%). 
Bellucci et al., 
2011 
BG_Ca - SiO₂ (47.2 mol.%), Na₂O (4.6 mol.%), CaO 
(45.6 mol.%) and P₂O₅ (2.6 mol.%). 
BioK - SiO₂ (46.1 mol.%), K₂O (24.4 mol.%), CaO 
(26.9 mol.%) and P₂O₅ (2.6 mol.%). 
Mg Series 
ICIE1 – (25 
Mg, 50 Mg, 
75 Mg and 
100 Mg 
- Fix amount of SiO₂ (49.46 mol.%), Na₂O 
(26.38 mol.%) and P₂O₅ (1.07 mol.%). 
- Various amount of CaO (23.08, 17.31, 
11.54, 5.77 and 0 mol.%) 
- Addition of MgO (0, 5.77, 11.54, 17.31 and 
23.08 mol.%). 
- Network connectivity value (2.13). 
Hill and Brauer, 
2011 
P Series I 
ICSW1, 
ICIE1, 
ICSW2, 
ICSW3, 
ICSW5 and 
ICSW4 
- Various amount of SiO₂ (51.06, 49.46, 
47.84, 44.47, 40.96 and 37.28 mol.%), 
Na₂O (26.10, 26.38, 26.67, 27.26, 27.87 
and 28.52 mol.%), CaO (22.84, 23.08, 
23.33, 23.85, 24.39 and 24.95 mol.%) and 
P₂O₅ (0, 1.07, 2.16, 4.42, 6.78 and 9.25 
mol.%). 
- All composition have different network 
connectivity values (2.08, 21.3, 2.18, 2.30, 
2.44 and 2.62). 
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Table 2.3: Modification in bioactive glass composition based on standard 45S5 
Bioglass
® 
(continued). 
Name of the 
bioactive 
glass 
Composition References 
P Series II 
ICSW1, 
ICSW6, 
ICSW7, 
ICSW8, 
ICSW10 and 
ICSW9 
- Various amount of SiO₂ (51.06, 48.98, 
47.07, 43.66, 40.71 and 38.14 mol.%), 
Na₂O (26.10, 26.67, 27.19, 28.12, 28.91 
and 29.62 mol.%), CaO (22.84, 23.33, 
23.78, 24.60, 25.31, 25.91 mol.%) and P₂O₅ 
(0, 1.02, 1.95, 3.62, 5.07 and 6.33 mol.%). 
- Network connectivity value (2.08). 
Hill and Brauer, 
2011 
BG (0, 10, 
50 and 
100%) 
- Fixed amount of SiO₂ (46.46 mol.%), Na₂O 
(26.38 mol.%) and P₂O₅ (1.07 mol.%).  
- Substitution of CaO (23.08 mol.%) with 
SrO (0, 10, 50 and 100 %).  
Gentleman et al., 
2010 
BioK - SiO₂ (46.1 mol.%), K₂O (24.4 mol.%), CaO 
(26.9 mol.%) and P₂O₅ (2.6 mol.%). 
Cannillo and Sola, 
2009 
 
2.3.1 Modifying the properties and composition of original bioactive glass  
Four series of BG compositions (Series A, Series B, Series C and Series D) as shown 
in Table 2.3 were prepared with various Nc (1.96, 2.04, 2.29, 2.47 and 2.74) and 
mixed alkali (Na2O and K2O) by modifying BG 45S5 composition (Elgayar et al., 
2005). The structures of all series of BG were investigated by calculating the density 
using Doweidars model. Furthermore, adding the mixed alkali oxide compositions 
such as Na2O and K2O enable the BG fabrication at lower temperature (Elgayar et 
al., 2005). 
31
P NMR spectra showed that P is present in orthophosphate form 
(Elgayar et al., 2005), where the function of phosphorus is to remove the calcium and 
sodium ions from the network, thus modifying the P role in the silicate network 
(O’Donnell et al., 2008a). Increasing silica amount in BG also contributed to increase 
in Nc values (Elgayar et al., 2005).  
Moreover, modifying the phosphate content affects bioactivity and Nc where HCA 
formation occurred rapidly as the phosphate amount increased (O’Donnell et al., 
2009). Phosphate contributes to deposition of calcium in vitro and in extracellular 
